Inizio Advisory Client Success Story
Using Inizio’s proprietary AssetNav tool, we provided information updated in real-time and delivered efficiencies by speeding up the project timeline.
An established biopharma company seeking to grow its leadership position in Head and Neck Cancer (HNSCC) needed to identify promising targets, technologies and clinical-stage assets to fill gaps in their portfolio and maintain their leadership in the category.
The top 5 actionable assets were selected, in close collaboration with a cross-functional client team. For each shortlisted asset, we evaluated the Target Opportunity Profile, clinical development path, business case and value prop, in order to support the client’s due diligence.
Learn more about AssetNav part of InizioNavigator.ai.
Supporting a new European division to launch brands in eight markets.
Read moreClient’s specialty product had a complicated oral therapy regimen requiring supplemental support to patients...
Read moreCASE STUDY (US) Virtual Oncology MSL team increases KOL engagement by 120%, exceeds insights gained goal by 600%.
Read more